Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Pfizer has urged a Florida federal judge to dismiss lawsuits claiming its birth control shot Depo-Provera can cause users to ...

Pfizer ( PFE -0.18%) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID ...

Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

The Washington State Employment Security Department has said that 100 workers are affected by Pfizer’s (NYSE:PFE) layoff, ...

In Q2 2025, Pfizer reported notable revenues from key oncology drugs: The increasing demand for drugs like Padcev and the introduction of new therapies such as Elrexfio, which generated $85 million in ...

One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...

This article will explore the concept of a long strangle options strategy, how to implement it with Pfizer, and the potential outcomes investors might face. A long strangle is an options trading ...

Pfizer said SSGJ-707 has shown promising efficacy and safety data, and 3Sbio plans to initiate the first Phase 3 study in China sometime this year. Based on this limited data, Cantor's Gould could ...